Background Studies examining the ε4 allele of the APOE gene as a factor affecting the severity of multiple sclerosis (MS) have yielded conflicting results. The focus of these studies on physical disability to the neglect of cognitive impairment is surprising in light of the associations between the ε4 allele and other dementia conditions. Only two studies examine the relationship between the ε4 allele and cognitive impairment.
Methods A neuropsychological test battery was administered to 263 MS patients, and their current disability status was evaluated. Genotypes were determined for APOE epsilon and for two promoter region polymorphisms (-219 G/T and -491 A/T).
Results Although effects were generally weak, female patients with the -491 AA genotype had a later age of disease onset, lower disability scores, and somewhat higher scores on the cognitive battery. Male patients with the ε2 allele had lower disability and higher scores on the cognitive battery. The ε4 allele was not related to physical disability, and there was no difference between ε4+and ε4– patients in overall cognitive performance. However, when patients with severe cognitive impairment were identified, a greater proportion (52%) of these patients had the ε4 allele than those in the unimpaired group (27%).
Conclusion An association with the ε4 allele was evident in this study, but only in cases of severe cognitive impairment.
Corder EH , Saunders AM , Strittmatter WJ , Schmechel DE , Gaskell PC , Small GW et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families . Science1993; 261: 921–923 .
2.
Poirier J , Davignon J , Bouthillier D , Kogan S , Bertrand P , Gauthier S . Apolipoprotein E polymorphism and Alzheimer's disease . Lancet1993; 342: 697–699 .
3.
Arendt T , Schindler C , Brückner MK , Eschrich K , Bigl V , Zedlick D et al. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein o4 allele . J Neurosci1997; 17: 516–529 .
4.
Smith GE , Bohac DL , Waring SC , Kokmen E , Tangalos EG , Ivnik RJ et al. Apolipoprotein E genotype influences cognitive ‘phenotype’ in patients with Alzheimer's disease but not in healthy control subjects . Neurology1998; 50: 355–362 .
5.
Chapman J , Sylantiev C , Nisipeanu P , Korczyn AD . Preliminary observations on apoE ε4 allele and progression of disability in multiple sclerosis . Arch Neurol1999; 56: 1484–1487 .
6.
Chapman J , Vinokurov S , Achiron A , Karussis DM , Mitosek-Szewczyk K , Birnbaum M et al. Apoe genotype is a major predictor of long-term progression of disability in MS . Neurology2001; 56: 312–316 .
7.
Dousset V , Gayou A , Brochet B , Iron A . ApoE polymorphism in multiple sclerosis . Mult Scler1998; 4 (Suppl 1): 357–357 .
8.
Evangelou N , Jackson M , Beeson D , Palace J . Association of the apoe ε4 allele with disease activity in multiple sclerosis . J Neurol Neurosurg Psychiatry1999; 67: 203–205 .
9.
Fazekas F , Strasser-Fuchs S , Kollegger H , Berger T , Kristoferitsch W , Schmidt H et al. Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis . Neurology2001; 57: 853–857 .
10.
Santos M , do Carmo Costa M , Edite Rio M , Jose Sa M , Monteiro M , Valenca A et al. Genotypes at the APOE and SCA2 loci do not predict the course of multiple sclerosis in patients of Portuguese origin . Mult Scler2004; 10: 153–157 .
11.
Høgh P , Oturai A , Schreiber K , Blinkenberg M , Jorgensen OS , Ryder L et al. Apolipoprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate . Mult Scler2000; 6: 226–230 .
12.
Masterman T , Hillert J , Lannfelt L , Corder EH . The e4 allele for APOE doubles risk of long-term prognosis in multiple sclerosis . Am J Hum Genet2000; 67 (Suppl 2): 1957–1957 .
13.
Schmidt S , Barcellos LF , DeSombre K , Rimmler JB , Lincoln RR , Bucher P et al. Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis . Am J Hum Genet2002; 7: 708–717 .
14.
Masterman T , Zhang Z , Hellgren D , Salter H , Anvret M , Lilius L et al. APOE genotypes and disease severity in multiple sclerosis . Mult Scler2002; 8: 98–103 .
15.
Enzinger C , Ropele S , Strasser-Fuchs S , Kapeller P , Schmidt H , Poltrum B et al. Lower levels of N acetylaspartate in multiple sclerosis with the apolipoprotein E ε4 allele . Arch Neurol2003; 60: 65–70 .
16.
Ferri C , Sciacca FL , Veglia F , Martinelli F , Comi G , Canal N et al. APOE epsilon2-4 and -491 polymorphisms are not associated with MS . Neurology1999; 53: 888–889 .
17.
Hamilton AJ , Graham CA , Kirk CW , McDonnell GV , Hawkins SA . ApoE gene variants and a disease progression index in multiple sclerosis . Mult Scler1999; 5 (Suppl 1): S34–S34 .
18.
Weatherby SJM , Mann CLA , Davies MB , Carthy D , Fryer AA , Boggild MD et al. Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis . Mult Scler2000; 6: 32–36 .
19.
Zakrzewska-Pniewska B , Styczynska M , Podlecka A , Samocka R , Peplonska B , Barcikowska M et al. Association of apolipoprotein E and myeloperoxidase genotypes to clinical course of familial and sporadic multiple sclerosis . Mult Scler2004; 10: 266–271 .
20.
Fazekas F , Strasser-Fuchs S , Schmidt H , Enzinger C , Ropele S , Lechner A et al. Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis . J Neurol Neurosurg Psychiatry2000; 69: 25–28 .
21.
Niino M , Kikuchi S , Fukazawa T , Yabe I , Tashiro K . Polymorphisms of apolipoprotein E and Japanese patients with multiple sclerosis . Mult Scler2003; 9: 382–386 .
22.
Savettieri G , Andreoli V , Bonavita S , Cittadella R , Caltagirone C , Fazio MC et al. Apolipoprotein E genotype does not influence the progression of multiple sclerosis . J Neurol2003; 250: 1094–1098 .
23.
Schreiber K , Oturai AB , Ryder LP , Madsen HO , Jørgensen OS , Svejgaard A et al. Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E) . Mult Scler2002; 8: 295–298 .
24.
Weatherby SJM , Mann CLA , Fryer AA , Strange RC , Hawkins CP , Stevenson VL et al. No association between the APOE epsilon4 allele and outcome and susceptibility in primary progressive multiple sclerosis . J Neurol Neurosurg Psychiatry2000; 68: 532–532 .
25.
Zwemmer JN , van Veen T , van Winsen L , van Kamp GJ , Barkhof F , Polman CH et al. No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis . Mult Scler2004; 10: 272–277 .
26.
Ballerini C , Campani D , Rombola G , Gran B , Nacmias B , Pia Amato M et al. Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis . Neurosci Lett2000; 296: 174–176 .
27.
Kantarci OH , Hebrink DD , Atkinson EJ , de Andrade M , McMurray C , Weinshenker BG . A population-based association study of apolipoprotein E variants with multiple sclerosis . Ann Neurol2000; 48: 124–124 .
28.
Kantarci OH , Hebrink DD , Achenbach SJ , Pittock SJ , Altintas A , Schaefer-Klein JL et al. Association of APOE polymorphisms with disease severity in MS is limited to women . Neurology2004; 62: 811–814 .
29.
Li YJ , Hauser MA , Scott WK , Martin ER , Booze MW , Qin XJ et al. Apolipoprotein E controls the risk and age at onset of Parkinson's disease . Neurology2004; 62: 2005–2009 .
30.
Zareparsi S , Camicioli R , Sexton G , Bird T , Swanson P , Kaye J et al. Age at onset of Parkinson disease and apolipoprotein E genotypes . Am J Med Genet2002; 107: 156–161 .
31.
Minthon L , Hesse C , Sjögren M , Englund E , Gustafson L , Blennow K . The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease . Neurosci Lett1997; 226: 65–67 .
32.
Rao SM , Leo GJ , Bernardin L , Unverzagt F . Cognitive dysfunction in multiple sclerosis: I. frequency, patterns, and prediction . Neurology1991; 41: 685–691 .
33.
Oliveri RL , Cittadella R , Sibilia G , Manna I , Valentino P , Gambardella A et al. APOE and risk of cognitive impairment in multiple sclerosis . Acta Neurol Scand1999; 100: 290–295 .
34.
Savettieri G , Messina D , Andreoli V , Bonavita S , Caltagirone C , Cittadella R et al. Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis .J Neurol2004; 251: 1208–1214 .
35.
Bullido MJ , Artiga MJ , Recuero M , Sastre I , Garcia MA , Aldudo J et al. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's disease . Nat Genet1998; 18: 69–71 .
36.
Artiga MJ , Bullido MJ , Sastre I , Recuero M , Garcia MA , Aldudo J et al. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene . FEBS Lett1998; 421: 105–108 .
37.
Bullido MJ , Valdivieso F . Apolipoprotein E gene promoter polymorphisms in Alzheimer's disease . Microsc Res Tech2000; 50: 261–267 .
38.
Heijmans BT , Slagboom PE , Gussekloo J , Droog S , Lagaay AM , Kluft C et al. Association of APOE ε2/ε3/ε4 and promoter gene variants with dementia but not cardiovascular mortality in old age . Am J Med Genet2002; 107: 201–208 .
39.
Lambert JC , Araria-Goumidi L , Myllykangas L , Ellis C , Wang JC , Bullido MJ et al. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk . Neurology2002; 59: 59–66 .
40.
Lambert JC , Pasquier F , Cottel D , Frigard B , Amouyel P , Chartier-Harlin MC . A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease . Hum Mol Genet1998; 7: 533–540 .
41.
Lambert JC , Berr C , Pasquier F , Delacourte A , Frigard B , Cottel D et al. Pronounced impact of Th1/ E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease . Hum Mol Genet1998; 7: 1511–1516 .
42.
Rebeck GW , Cheung BS , Growdon WB , Deng A , Akuthota P , Locascio J et al. Lack of independent associations of apoliproprotein E promoter and intron 1 polymorphisms with Alzheimer's disease . Neurosci Lett1999; 272: 155–158 .
43.
McDonald WI , Compston A , Edan G , Goodkin D , Hartung HP , Lublin FD , McFarland HF . Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis . Ann Neurol2001; 50: 121–127 .
44.
Lublin FD , Reingold SC . Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis . Neurology1996; 46: 907–911 .
45.
Kurtzke JF . Rating neurologic impairment in multiple sclerosis: and expanded disability status scale (EDSS) . Neurology1983; 33: 1444–1452 .
46.
Lynch SG , Parmenter BA , Denney DR . The association between cognitive impairment and physical disability in multiple sclerosis . Mult Scler2005; 11: 469–476 .
